Vertex Pharmaceuticals Inc / Ma

PREVAIL INNOVATIVE WEALTH ADVISORS, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

15,613

Value ($000)

7,078

Weight

1.3%

2025 Q3 - 2025 Q4 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	7,078	1.3%	15,613	12/31/2025
2025 Q3	11/13/2025	5,953	1.2%	15,200	9/30/2025